Seth A. Eisen

Seth A. Eisen

Auto-generated profile, based on publicly available information

Seth A. Eisen

Washington University School of Medicine, St, Louis, MO, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1999 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
WSWendy S. Slutske
Wendy S. Slutske
WTWilliam R. True
William R. True
JSJeffrey Scherrer
Jeffrey Scherrer
AHAndrew C. Heath
Andrew C. Heath
KBKathleen K. Bucholz
Kathleen K. Bucholz
MTMing T. Tsuang
Ming T. Tsuang

12 April 2025 in Rheumatology
Verified
Journal Article
Closed access
JSJasvinder Singh
Jasvinder Singh
LHLarry R Hearld
Larry R Hearld
SESeth Eisen
Seth Eisen
WCW Winn Chatham
W Winn Chatham
SNSonali Narain
Sonali Narain
ICImplementing DEcision-Aid for Lupus in clinics (IDEAL) Consortium
Implementing DEcision-Aid for Lupus in clinics (IDEAL) Consortium
Objective: The objective of this study was to examine the clinical outcomes during the implementation of a self-administered patient decision-aid (PtDA) for lupus. Methods: We provided an effective computerized lupus PtDA in 15 rheumatology outpatient clinics 2019–2024 (including the COVID pandemic). We undertook Organizational Readiness to Implement Change Surveys (ORICs) and Team Learning and Psychological Safety Surveys (TLPSSs) at baseline. The primary study outcome objective measure, percent penetration/reach, was defined as the number of patients who viewed the lupus PtDA at the end of the study, divided by the total number of eligible patients (times 100). We used validated clinical personnel surveys to examine the perceived lupus PtDA appropriateness, acceptability, feasibility, success, and permanence, at 4 months, 12 months and 24 months post-PtDA implementation. Results: Among the sites, the clinical personnels’ (n = 184) baseline ORIC commitment and efficacy scores (a 0–5 scale, higher = better) ranged from 3.5 to 4.2, and 3.4 to 4.4, respectively; the TLPSS scores (a 0–7 scale, higher = better) were 3.9–5.5 for internal learning, 3.7–5.6 for external learning, and 4.3–5.5 for psychological safety. The penetration (primary outcome) among 15 geographically diverse US rheumatology clinics ranged from 3% to 44%. We found that the total number of providers in the clinic was positively associated with higher penetration. Clinical personnel–perceived lupus PtDA outcomes were optimal at 4 months (all scale scores ranged from 1 to 5, higher = better): (i) appropriateness, 3.43 (s.d. 0.86); (ii) acceptability, 3.53 (s.d. 0.83); (iii) feasibility, 3.44 (s.d. 0.71); (iv) success, 3.41 (s.d. 0.73); and (v) permanence, 3.22 (s.d. 0.74). Conclusion: We implemented a lupus PtDA with varied success rates during the COVID pandemic; more providers were associated with higher clinic penetration. Clinical personnel perceived high lupus PtDA appropriateness, acceptability, feasibility, success, and permanence that persisted up to 24 months. Trial Registration: ClinicalTrials.gov, http://clinicaltrials.gov, NCT03735238.

3 March 2025 in ACR Open Rheumatology
Verified
Journal Article
Open access
ACAlissa Chandler
Alissa Chandler
MHMohammed Hamid
Mohammed Hamid
ZJZiqiao Jiao
Ziqiao Jiao
KHKelsey Hulcher
Kelsey Hulcher
ISIsha Sharma
Isha Sharma
AKAlfred Kim
Alfred Kim
Objective: The purpose of this study was to pilot test a patient‐reported social risk factor (SRF) screening tool among rheumatology outpatients and to examine the distribution of SRFs in this population.Methods: A SRF screening tool was completed electronically by patients. Patients were screened for four core SRF domains (financial strain, housing instability, food insecurity, and transportation needs) and four supplemental SRF domains (physical inactivity, social isolation, stress, and depression). Data from the electronic health record were extracted for patients with at least one domain screened who were seen by participating rheumatology providers between January 1 and October 31, 2023. Descriptive statistics and multivariable logistic regressions were used to examine trends and associations of SRFs in this population.Results: The sample included 483 patients, and 84% of patients screened positive for at least one SRF. Physical inactivity (73%, 311 of 429) and social isolation (58%, 212 of 367) were the most common SRFs. Prevalence of core SRF domains was 35% for financial strain (145 of 412), 22% for housing instability (82 of 370), 23% for food insecurity (96 of 420), and 11% for transportation needs (48 of 427). Sociodemographic groups with higher prevalence of SRFs included patients reporting Medicaid insurance, younger age, Black race, or unmarried status. Multivariate analyses showed that Medicaid insurance increased odds of reporting SRFs in all core domains.Conclusion: Our SRF screening identified a high burden of SRFs among rheumatology outpatients, giving a new level of detail into patients’ barriers and possible needs. Future work will uncover associations between SRFs and clinical outcomes and evaluate the impact of interventions to address SRFs.

10 January 2022 in Journal of Clinical Densitometry
Verified
Journal Article
Closed access
MMMahshid Mohseni
Mahshid Mohseni
SESeth Eisen
Seth Eisen
SSShannon Stum
Shannon Stum
RCRoberto Civitelli
Roberto Civitelli

30 May 2023 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Open access
PDF file
MSMartin W Schoen
Martin W Schoen
KCKenneth R. Carson
Kenneth R. Carson
SESeth A. Eisen
Seth A. Eisen
CBCharles L. Bennett
Charles L. Bennett
SLSuhong Luo
Suhong Luo
KSKristen M. Sanfilippo
Kristen M. Sanfilippo

1 January 2011 in Translational Research
Verified
Journal Article
Open access
BDBrian C. Drolet
Brian C. Drolet
NLNancy M. Lorenzi
Nancy M. Lorenzi
MCMassimo Cugno
Massimo Cugno
ZAZiyad Al‐Aly
Ziyad Al‐Aly
HPHui Pan
Hui Pan
SRSabera Ruždijić
Sabera Ruždijić